Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation

Autor: Jesus Fernandez-Sojo, Joan Cid, Carmen Azqueta, Elena Valdivia, Lluis Martorell, Margarita Codinach, Julia Marsal, Alberto Mussetti, Albert Esquirol, Maria Trabazo, Maria Isabel Benitez, Christelle Ferra, Maria Laura Fox, Mónica Linares, Eva Alonso, Enric García-Rey, Nadia García-Muñoz, Laura Medina, Nerea Castillo-Flores, Ferran Vall-Llovera, Antoni Garcia, Asuncion Pinacho, Carme Talarn, Jose Garcia Arroba, Rosa Coll, Mireia Santos, Oliver Valero, Enric Carreras, Miquel Lozano, Sergio Querol

Publikováno v: BONE MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26ad82b2d28070d74f4cf3dd880ea5eb
https://doi.org/10.1038/s41409-022-01722-6

Impact of the Use of Bendamustine Immediately before the Collection of Hematopoietic Stem Cells in Lymphoma. a Study By the Geltamo Group

Autor: Carolina Martínez-Laperche, Mariana Bastos-Oreiro, Ana Pilar Gonzalez, Daniel F. Garcia, Raul Cordoba, Antonio Salar, Ana Isabel Jiminez Ubieto, Valeria Delgado, Javier Anguita, Juan-Manuel Sancho, Jose Garcia-Arroba, José Tejada Fernández

Publikováno v: Blood. 138:1771-1771

Introduction: Bendamustine is a hybrid alkylating agent with high efficacy in different haematological malignancies, especially for lymphomas. Data about the capacity of peripheral blood stem cell (PBSC) mobilization or a possible stem cell toxicity

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d1b90e26a32613faac5821ca249899e
https://doi.org/10.1182/blood-2021-150769

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.